We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BAC BV Collaborates with Life Technologies to Provide New HPLC Affinity Columns
Product News

BAC BV Collaborates with Life Technologies to Provide New HPLC Affinity Columns

BAC BV Collaborates with Life Technologies to Provide New HPLC Affinity Columns
Product News

BAC BV Collaborates with Life Technologies to Provide New HPLC Affinity Columns


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BAC BV Collaborates with Life Technologies to Provide New HPLC Affinity Columns"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BAC BV, has announced a strategic collaboration with Life Technologies, the global manufacturer of molecular diagnostic and research-use products, to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life Technologies’ POROS® chromatography media and pre-packed HPLC columns.

This new suite of products will provide an unparalleled range of specificities and column formats for applications from discovery through to process monitoring.

The collaboration will create a range of ready-to-use HPLC columns pre-packed with CaptureSelect affinity ligands immobilized on POROS chromatography media.

Designed for the high pressures and flow rates necessary to provide the real-time results demanded for biopharmaceutical quality assurance needs, the unique selectivity of these columns will support Process Analytical Technology (PAT) for virtually any biopharmaceutical manufacturing process.

“We are very excited to be able to provide a continuously evolving range of specificities and column formats that will allow more researchers to access the benefits of CaptureSelect technology”, commented Laurens Sierkstra, CEO of BAC. “Scientists will be able to routinely use CaptureSelect ligands in formats that support QbD approaches for process development and monitoring.”

Advertisement